Lyophilized mucoadhesive-dendrimer enclosed matrix tablet for extended oral delivery of albendazole

European Journal of Pharmaceutics and Biopharmaceutics

Volumn 102, Issue , 2016, Pages 202-213

  Mansuri, Shakir ^a   Kesharwani, Prashant ^b   Tekade, Rakesh Kumar ^c   Jain, Narendra Kumar ^a  

^a DR H S GOUR UNIVERSITY   (India)

^b WAYNE STATE UNIVERSITY   (United States)

^c INTERNATIONAL MEDICAL UNIVERSITY   (Malaysia)

Author keywords

Albendazole; Matrix tablet; MRT; Muco PPI; Mucoadhesion

Indexed keywords

ALBENDAZOLE; DENDRIMER; ADHESIVE AGENT; ANTHELMINTIC AGENT; CHITOSAN; DELAYED RELEASE FORMULATION; DRUG CARRIER; TABLET;

ANIMAL EXPERIMENT; AREA UNDER THE CURVE; ARTICLE; CONTROLLED STUDY; DRUG BIOAVAILABILITY; DRUG BLOOD LEVEL; DRUG DELIVERY SYSTEM; DRUG HALF LIFE; DRUG SOLUBILITY; DRUG STABILITY; ELECTRON MICROSCOPY; FREEZE DRYING; HEMOLYSIS; INFRARED SPECTROSCOPY; MALE; MATRIX TABLET; MAXIMUM PLASMA CONCENTRATION; MEAN RESIDENCE TIME; MUCOADHESION; NONHUMAN; PROTON NUCLEAR MAGNETIC RESONANCE; RAT; SUSTAINED DRUG RELEASE; TABLET FORMULATION; TIME TO MAXIMUM PLASMA CONCENTRATION; ULTRAVIOLET SPECTROSCOPY; ADMINISTRATION AND DOSAGE; ANIMAL; BIOAVAILABILITY; CHEMISTRY; DELAYED RELEASE FORMULATION; HALF LIFE TIME; MEDICINAL CHEMISTRY; METABOLISM; MUCOSA; ORAL DRUG ADMINISTRATION; PROCEDURES; RABBIT; SPRAGUE DAWLEY RAT; TABLET;

ADHESIVES; ADMINISTRATION, ORAL; ALBENDAZOLE; ANIMALS; ANTHELMINTICS; BIOLOGICAL AVAILABILITY; CHEMISTRY, PHARMACEUTICAL; CHITOSAN; DELAYED-ACTION PREPARATIONS; DENDRIMERS; DRUG CARRIERS; DRUG DELIVERY SYSTEMS; FREEZE DRYING; HALF-LIFE; MALE; MUCOUS MEMBRANE; RABBITS; RATS; RATS, SPRAGUE-DAWLEY; TABLETS;

EID: 84961647316     PISSN: 09396411     EISSN: 18733441     Source Type: Journal    
DOI: 10.1016/j.ejpb.2015.10.015     Document Type: Article

References (68)

1. P. Dwivedi, R.K. Tekade, and N.K. Jain Nanoparticulate carrier mediated intranasal delivery of insulin for the restoration of memory signaling in Alzheimer's disease Curr. Nanosci. 9 2013 46 55
2. A. Dhole, P. Gaikwad, V. Bankar, and S. Pawar A review on floating multiparticulate drug delivery system: a novel approach to gastric retention Int. J. Pharm. Sci. Rev. Res. 6 2011 205 211
3. A.A. Deshpande, C.T. Rhodes, N.H. Shah, and A.W. Malick Controlled-release drug delivery systems for prolonged gastric residence: an overview Drug Dev. Ind. Pharm. 22 1996 31 39
4. Y. Luo, Z. Teng, Y. Li, and Q. Wang Solid lipid nanoparticles for oral drug delivery: chitosan coating improves stability, controlled delivery, mucoadhesion and cellular uptake Carbohydr. Polym. 20 2015 221 229
5. J.S. Suk, S.K. Lai, Y.Y. Wang, L.M. Ensign, P.L. Zeitlin, M.P. Boyle, and J. Hanes The penetration of fresh undiluted sputum expectorated by cystic fibrosis patients by non-adhesive polymer nanoparticles Biomaterials 30 2009 2591 2597
6. M. Cuña, M.J. Alonso, and D. Torres Preparation and in vivo evaluation of mucoadhesive microparticles containing amoxicillin-resin complexes for drug delivery to the gastric mucosa Eur. J. Pharm. Biopharm. 51 2001 199 205
7. C. Li, Z. Liu, X. Yan, W. Lu, and Y. Liu Mucin-controlled drug release from mucoadhesive phenylboronic acid-rich nanoparticles Int. J. Pharm. 1 2015 261 264
8. B.C. Tang, M. Dawson, S.K. Lai, Y.Y. Wang, J.S. Suk, M. Yang, P. Zeitlin, M.P. Boyle, J. Fu, and J. Hanes Biodegradable polymer nanoparticles that rapidly penetrate the human mucus barrier Proc. Natl. Acad. Sci. USA 106 2009 19268 19273
9. J.K. Vasir, K. Tambwekar, and S. Garg Mucoadhesive tablets as a controlled drug delivery system Int. J. Pharm. 255 2003 13 32
10. K.R. Kamath, K. Park, J. Swarbrick, and J.C. Boylon Mucosal adhesive preparations Encycl. Pharm. Technol. 1 1994 133
11. C.W. Huang, V. Kearney, S. Moeendarbari, R.Q. Jiang, P. Christensen, X. Sun, W.H. Mao, and Y.W. Hao Hollow gold nanoparticals as biocompatible radiosensitizer: an in vitro proof of concept study J. Nano Res. 32 2015 106 112
12. R.K. Tekade Editorial: contemporary siRNA therapeutics and the current state-of-art Curr. Pharm. Des. 21 31 2015 4527 4528
13. R.K. Tekade, R.G. Maheshwari, P.A. Sharma, M. Tekade, and A.S. Chauhan SiRNA therapy, challenges and underlying perspectives of dendrimer as delivery vector Curr. Pharm. Des. 21 2015 4614 4636
14. P. Kesharwani, R.K. Tekade, and N.K. Jain Generation dependent safety and efficacy of folic acid conjugated dendrimer based anticancer drug formulations Pharm. Res. 32 2014 1438 1450
15. S.R. Youngren, R.K. Tekade, B. Gustilo, P.R. Hoffmann, and M.B. Chougule STAT6 siRNA matrix-loaded gelatin nanocarriers: formulation, characterization, and ex vivo proof of concept using adenocarcinoma cells BioMed Res. Int. 2013 2013 858946
16. N.K. Jain, and R.K. Tekade Dendrimers for enhanced drug solubilization Drug Delivery Strategies for Poorly Water-Soluble Drugs 2013 John Wiley & Sons Ltd 373 409
17. N. Mody, R.K. Tekade, N.K. Mehra, P. Chopdey, and N.K. Jain Dendrimer, liposomes, carbon nanotubes and PLGA nanoparticles: one platform assessment of drug delivery potential AAPS PharmSciTech 15 2014 388 399
18. R.N. Prajapati, R.K. Tekade, U. Gupta, V. Gajbhiye, and N.K. Jain Dendimer-mediated solubilization, formulation development and in vitro-in vivo assessment of piroxicam Mol. Pharm. 6 2009 940 950
19. D.A. Tomalia, H. Baker, J.R. Dewald, M. Hall, G. Kallos, S. Martin, J. Roeck, J. Ryder, and P. Smith A new class of polymers: starburst dendritic molecules Polym. J. 17 1985 117 132
20. R.K. Tekade, P. Vijayarajkumar, and N.K. Jain Dendrimers in oncology: an expanding horizon Chem. Rev. 109 2009 49 87
21. P. Kesharwani, R.K. Tekade, K. Jain, and N.K. Jain Generation dependent cancer targeting potential of poly(propyleneimine) dendrimer Biomaterials 35 2014 5539 5548
22. P. Kesharwani, R.K. Tekade, K. Jain, and N.K. Jain Formulation development and in vitro-in vivo assessment of fourth generation PPI dendrimer as cancer targeting vector Nanomedicine (London) 9 2014 2291 2308
23. P. Kesharwani, V. Gajbhiye, R.K. Tekade, and N.K. Jain Evaluation of dendrimer safety and efficacy through cell line studies Curr. Drug Targets 12 2011 1478 1497
24. A. Bennett, and H. Guyatt Reducing intestinal nematode infection: efficacy of albendazole and mebendazole Parasitol. Today 16 2000 71 74
25. R.G.S. Maheshwari, R.K. Tekade, G. Dharvekar, and D.K. Jain Ethosomes and ultradeformable liposomes for transdermal delivery of clotrimazole: a comparative assessment Saudi Pharm. J. 20 2012 161 170
26. E.M.M. De Brabander-van den Berg, and E.W. Meijer Poly (propylene imine) dendrimers: large scale synthesis by heterogeneously catalyzed hydrogenation Angew. Chem., Int. Ed. Engl. 32 1993 1308 1311
27. R.K. Tekade, T. Dutta, V. Gajbhiye, and N.K. Jain Exploring dendrimer towards dual drug delivery: pH responsive simultaneous drug-release kinetics J. Microencapsul. 15 2008 1 10
28. R.S. Dhakad, R.K. Tekade, and N.K. Jain Cancer targeting potential of folate targeted nanocarrier under comparative influence of tretinoin and dexamethasone Curr. Drug Delivery 10 2013 477 491
29. R.K. Tekade, and M.B. Chougule Formulation development and evaluation of hybrid nanocarrier for cancer therapy: Taguchi orthogonal array based design BioMed Res. Int. 2013 2013 712678
30. R.G.S. Maheshwari, S. Thakur, S. Singhal, R.P. Patel, M. Tekade, and R.K. Tekade Chitosan encrusted nonionic surfactant based vesicular formulation for topical administration of ofloxacin Sci. Adv. Mater. 7 2015 1163 1176
31. R.K. Tekade, S.R. Youngren-Ortiz, H. Yang, R. Haware, and M.B. Chougule Designing hybrid onconase nanocarriers for mesothelioma therapy: a Taguchi orthogonal array and multivariate component driven analysis Mol. Pharm. 11 2014 3671 3683
32. P. Kesharwani, R.K. Tekade, V. Gajbhiye, K. Jain, and N.K. Jain Cancer targeting potential of some ligand-anchored poly (propyleneimine) dendrimers: a comparison Nanomed. Nanotechnol. Biol. Med. 7 2011 295 304
33. S. Thakur, R.K. Tekade, P. Kesharwani, and N.K. Jain The effect of polyethylene glycol spacer chain length on the tumor targeting potential of folate modified PPI dendrimers J. Nanoparticle Res. 15 2013 1625
34. 2 specific delivery of methotrexate by dendrimer conjugated anti-HER2 mAb Nanotechnology 19 2008 5102 5109
35. P.V. Kumar, A. Asthana, T. Dutta, and N.K. Jain Intracellular macrophage uptake of rifampicin loaded mannosylated dendrimers J. Drug Target. 14 2006 546 556
36. H.H. Salman, C. Gamazo, M. Agueros, and J.M. Irache Bioadhesive capacity and immunoadjuvant properties of thiamine-coated nanoparticles Vaccine 23 2007 8123 8132
37. M. Momin, and K. Pundarikakshudu In vitro studies on guar gum based formulation for the colon targeted delivery of Sennosides J. Pharm. Pharm. Sci. 7 2004 325 331
38. Y.S.R. Krishanaiah, K. Latha, L.N. Rao, R.S. Karthukeyan, P. Bharskar, and V.J. Satyanarayana Development of colon targeted oral guar gum matrix tablets of Albendazole for the treatment of helminthiasis Indian J. Pharm. Sci. 65 2003 378 385
39. L. Lachman, A. Herbert, and J.L. Liberman The Theory and Practice of Industrial Pharmacy third ed. 1991 Varghese Publishing House Mumbai 300 318
40. Pharmacopoeia of India; Ministry of Health and Family Welfare, Govt. of India, vol. 2, Controller of Publications, New Delhi, 2007, p. 1795.
41. The United States Pharmacopoeia-XXIV, US Pharmacopoeial Convention Inc. Rockville, MD 20852, 2004, pp. 2085-2622.
42. K. Vermani, S. Garg, and J.D. Lourence Assembly for in vitro measurement of bioadhesive strength and retension characteristics in simulated vaginal environment Drug Dev. Ind. Pharm. 28 2002 1133 1146
43. D.L. Wise, Handbook of Pharmaceutical Controlled Release, Technol. 1st Indian Reprint, 2005, pp. 263-265.
44. C. Jackson, and I. Udonkang In-vitro studies of xanthan gum based formulation of Albendazole for colon targeted delivery Int. J. Pharm. Biomed. Res. 2 2011 59 63
45. U.S. Bagul, R.V. Patil, N.V. Patil, and K.N. Gujar Trilayer mucoadhesive gastro retentive tablets: formulation and in vitro evaluation J. Pharm. Res. 5 2012 2463 2466
46. J. Ali, R. Khar, A. Ahuja, and R. Karla Buccoadhesive erodible disk for treatment of orodental infections design and characterization Int. J. Pharm. 283 2002 99 103
47. A. Gupta, S. Garg, and R. Khar Measurement of bioadhesive strength of mucoadhesive buccal tablets: design of in vitro assembly Indian Drugs 30 1992 152 155
48. U. Bagul, K. Gujar, S. Dhat, S. Aniaphale, and M. Bhavsar In vitro study of mucoadhesive strength of polymers for mucoadhesive drug delivery systems Int. J. Curr. Pharm. Res. 1 2009 42 46
49. D. Ray, and A.K. Prusty Designing and in-vitro studies of gastric floating tablets of tramadol hydrochloride Int. J. Appl. Pharm. 2 2010 12 16
50. J.A. Ravala, and M.M. Patel Design and development of swellable and mucoadhesive gastroretentive tablets of amoxicillin Asian J. Pharm. Sci. 6 2011 141 150
51. D. Bhadra, S. Bhadra, S. Jain, and N.K. Jain A PEGylated dendritic nanoparticulate carrier of fluorouracil Int. J. Pharm. 257 2003 111 124
52. S.K. Sahebrao, R.S. Shendge, and K.M. Vinayaka Formulation and in vitro evaluation of dextrin matrix tablet of albendazole for colon drug delivery J. Pharm. Res. 2 2009 429 431
53. R.K. Tekade, M. Tekade, M. Kumar, and A.S. Chauhan Dendrimer-stabilized smart-nanoparticle (DSSN) platform for targeted delivery of hydrophobic antitumor therapeutics Pharm. Res. 32 2015 910 928
54. P.K. Chopdey, R.K. Tekade, N.K. Mehra, N. Mody, and N.K. Jain Glycyrrhizin conjugated dendrimer and multi-walled carbon nanotubes for liver specific delivery of doxorubicin J. Nanosci. Nanotechnol. 15 2015 1088 1100
55. P.K. Metia, and A.K. Bandyopadhyay In vitro evaluation of novel mucoadhesive buccal tablet of oxytocin prepared with Diospsyros peregina fruit mucilages Pharm. Soc. Jpn. 4 2008 603 609
56. S. Saphier, A. Rosner, R. Brandeis, and Y. Karton Gastro intestinal tracking and gastric emptying of solid dosage forms in rats using X-ray imagining Int. J. Pharm. 388 2010 190 195
57. Z.Y. Cai, P. Galettis, Y. Lu, D.L. Morris, and M.H. Pourgholami Pharmacokinetics of albendazole in New Zealand white rabbits: oral versus intraperitoneal administration Anticancer Res. 27 2007 417 422
58. D. Kitzman, K.J. Cheng, and L. Fleckenstein HPLC assay for albendazole and metabolites in human plasma for clinical pharmacokinetic studies J. Pharm. Biomed. Anal. 30 2002 801 813
59. A. Kulik, W. Bialecka, M. Podolska, B.K. Puchniarz, and A. Mazurek HPLC method for identification and quantification of benzimidazole derivatives in antiparasitic drugs Pharm. Drug Res. 68 2011 823 829
60. V. Gajbhiye, P.V. Kumar, R.K. Tekade, and N.K. Jain PEGylated PPI dendritic architectures for sustained delivery of H 2 receptor antagonist Eur. J. Med. Chem. 44 2009 1155 1166
61. A. Jain, Y. Gupta, and S.K. Jain Perspectives of biodegradable natural polysaccharides for site-specific drug delivery to the colon J. Pharm. Pharm. Sci. 10 2007 86 128
62. T. Higuchi Mechanism of sustained action medication J. Pharm. Sci. 52 1963 1145 1149
63. M. Donbrow, and Y. Samuelov Zero order drug delivery from double-layered porous films: release rate profiles from ethylcellulose, hydroxypropyl cellulose and polyethylene glycol mixtures J. Pharm. Pharmacol. 32 1980 463 470
64. H.A. Merchant, H.M. Shoaib, J. Tazeen, and R.I. Yousuf Once-daily tablet formulation and in vitro release evaluation of cefpodoxime using hydroxypropyl methylcellulose: a technical note AAPS PharmSciTech 7 2006 E178 E183
65. P.R. Veerareddy, S. Bajjuri, K. Sanka, R. Jukanti, S. Bandari, R.K. Ajmeru, and A.R. Potu Formulation and evaluation of gastroretentive dosage form of ofloxacin Stamford J. Pharm. Sci. 4 2011 9 18
66. M. Umarunnisha, S. Palanichamy, M. Rajesh, S. Jeganath, and A. Thangathirupathi Formulation and evaluation of matrix tablets of Famotidine using hydrophilic polymer Arch. Appl. Sci. Res. 2 2010 212 220
67. S.C. Basak, K.S. Kumar, and M. Ramalingam Design and release characteristics of sustained release tablet containing metformin HCl Brazilian J. Pharm. Sci. 44 2008 477 483
68. M.S. Reza, M.A. Quadir, and S.S. Haider Development of theophylline sustained release dosage form based on Kollidon SR Pak. J. Pharm. Sci. 15 2002 63 702